Shiyu Jiang
Johns Hopkins University(US)Sun Yat-sen University(CN)Duke University(US)Shanghai Jiao Tong University(CN)Changchun Normal University(CN)Fudan University(CN)Westlake University(CN)Fudan University Shanghai Cancer Center(CN)MetaMateria (United States)(US)Third Affiliated Hospital of Sun Yat-sen University(CN)Heilongjiang University(CN)Rice University(US)Wuhan Institute of Technology(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, CNS Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders
Most-Cited Works
- → Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)(2020)455 cited
- → Differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and Global Burden of Disease 2019(2023)72 cited
- → Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study(2020)65 cited
- → Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma(2016)57 cited
- → Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial(2024)46 cited
- → Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients(2020)39 cited